Global /China /Healthcare /Medical Devices /300529

Jafron Biomedical Co.,Ltd.

300529

• SHE: 300529 • Delayed

19.04CNY -0.1%

2.81 USD

As of 15 June 2026, Jafron Biomedical Co.,Ltd. has a market cap of $2.18B USD, ranking #6655 globally and #1573 in China. It ranks #534 in the Healthcare sector, and #113 in the Medical Devices industry.

Global Rank

6655

Country Rank

1573

Sector Rank

534

Industry Rank

113

Key Stats

Market Cap

$2.18BUSD

14.74B CNY

Enterprise Value

$1.97BUSD

13.35B CNY

Revenue (TTM)

$298.79MUSD

2.02B CNY

EBITDA (TTM)

$126.27MUSD

854.53M CNY

Net Income (TTM)

$83.32MUSD

564.55M CNY

EBITDA Margin

42%

Profit Margin

28%

PE Ratio

25.8

Forward PE

23.5

PS Ratio

7.3

PB Ratio

4.0

EV/EBITDA

15.6

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Devices

CEO

Fan Dong open_in_new

Employees

2,500

Founded

1989

Website

jafroninternational.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.1%	3.8%	7.6%	-6.6%	-11%	-3.1%	-13%	-34%	-80%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	300529 健帆生物科技集团股份有限公司 Class A ISIN: CNE100002995 Shares Out.: Shares Outstanding: 772.688M¹ Shares Float: 590.261M² TV: TradingView: SZSE: 300529 SA: Stock Analysis: SHE: 300529 YF: Yahoo Finance: 300529.SZ GF: Google Finance: SHE: 300529 BA: Barron's: 300529 MS: Morningstar: XSHE: 300529	19.04 CNY	TV: TradingView: SZSE: 300529 SA: Stock Analysis: SHE: 300529 YF: Yahoo Finance: 300529.SZ GF: Google Finance: SHE: 300529 BA: Barron's: 300529 MS: Morningstar: XSHE: 300529

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Jafron Biomedical Co.,Ltd.

Jafron Biomedical Co.,Ltd. engages in the research and development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.

Similar Companies

Industry: Medical Devices (China)

Name	Market Cap (USD) diff.	PE	Country
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.06B 203.66B CNY 1K%	26.0	China
Shanghai United Imaging Healthcare Co., Ltd. SSE: 688271	$13.61B 92.23B CNY 526%	48.5	China
Shenzhen New Industries Biomedical Engineering Co., Ltd. SHE: 300832	$5.61B 38.02B CNY 158%	23.4	China
Intco Medical Technology Co., Ltd. SHE: 300677	$5.52B 37.43B CNY 154%	52.7	China
APT Medical Inc. SSE: 688617	$5.04B 34.14B CNY 132%	39.6	China
Andon Health Co., Ltd. SHE: 002432	$4.55B 30.86B CNY 109%	13.7	China

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 8K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 7K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 7K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 6K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 5K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 5K%	22.2	Ireland

chevron_leftBack